Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381715852> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4381715852 endingPage "e419" @default.
- W4381715852 startingPage "e413" @default.
- W4381715852 abstract "The aim of this study was to compare oral and IV administrations of 18 F-NaF PET/CT for detection of suspicious bone metastatic lesions of breast and prostate cancers.Thirty-six patients with breast (n = 23) or prostate (n = 13) cancers and high risk for bone metastases were prospectively evaluated. All patients underwent 2 PET/CT studies after IV and oral 18 F-NaF administration within a 2 to 23 days interval between them. The maximum SUVs from the same suspicious lesions (≤5 index lesions per patient) in both studies were measured. The target-to-background ratio (TBR), defined as the relation between the lesion maximum SUV and the whole skeletal mean SUV, was calculated for each lesion. The TBRs in the same lesion calculated using the 2 administration routes were compared. The agreements between 2 physicians in the definition of the number of lesions in both studies were also assessed using weighted κ.One hundred thirty-four pairs of lesions were analyzed. There was no significant statistical difference between the median TBRs ( P = 0.212) for IV (10.33) and oral (10.85). Excellent intraobserver agreement was observed between IV and oral routes: weighted κ of 1.0 (95% confidence interval, 0.92-1.0) and 0.92 (95% confidence interval, 0.81-0.99) for physicians 1 and 2, respectively. The interobserver coefficients were 0.82 and 0.87 for oral versus oral and IV versus IV, respectively.18 F-NaF PET/CT studies using oral and IV routes present comparable performance; thus, it is possible to use oral route in patients with difficult venous access." @default.
- W4381715852 created "2023-06-24" @default.
- W4381715852 creator A5001973045 @default.
- W4381715852 creator A5021756525 @default.
- W4381715852 creator A5038100577 @default.
- W4381715852 creator A5074217620 @default.
- W4381715852 creator A5086569955 @default.
- W4381715852 creator A5087763708 @default.
- W4381715852 date "2023-06-23" @default.
- W4381715852 modified "2023-10-16" @default.
- W4381715852 title "Comparison of Oral and IV 18F-NaF PET/CT Administration in the Assessment of Bone Metastases in Patients With Breast or Prostate Cancers" @default.
- W4381715852 cites W1804083852 @default.
- W4381715852 cites W1979069118 @default.
- W4381715852 cites W1989560814 @default.
- W4381715852 cites W2039372269 @default.
- W4381715852 cites W2083793124 @default.
- W4381715852 cites W2112557099 @default.
- W4381715852 cites W2133012565 @default.
- W4381715852 cites W2140978366 @default.
- W4381715852 cites W2147477216 @default.
- W4381715852 cites W2152935357 @default.
- W4381715852 cites W2157628159 @default.
- W4381715852 cites W2158110141 @default.
- W4381715852 cites W2161081220 @default.
- W4381715852 cites W2164777277 @default.
- W4381715852 cites W2415720263 @default.
- W4381715852 cites W2520295035 @default.
- W4381715852 cites W2767433150 @default.
- W4381715852 cites W2972011015 @default.
- W4381715852 cites W3191534679 @default.
- W4381715852 doi "https://doi.org/10.1097/rlu.0000000000004745" @default.
- W4381715852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37351903" @default.
- W4381715852 hasPublicationYear "2023" @default.
- W4381715852 type Work @default.
- W4381715852 citedByCount "0" @default.
- W4381715852 crossrefType "journal-article" @default.
- W4381715852 hasAuthorship W4381715852A5001973045 @default.
- W4381715852 hasAuthorship W4381715852A5021756525 @default.
- W4381715852 hasAuthorship W4381715852A5038100577 @default.
- W4381715852 hasAuthorship W4381715852A5074217620 @default.
- W4381715852 hasAuthorship W4381715852A5086569955 @default.
- W4381715852 hasAuthorship W4381715852A5087763708 @default.
- W4381715852 hasConcept C121608353 @default.
- W4381715852 hasConcept C126322002 @default.
- W4381715852 hasConcept C126838900 @default.
- W4381715852 hasConcept C142724271 @default.
- W4381715852 hasConcept C2776235491 @default.
- W4381715852 hasConcept C2777056448 @default.
- W4381715852 hasConcept C2780192828 @default.
- W4381715852 hasConcept C2781156865 @default.
- W4381715852 hasConcept C2989005 @default.
- W4381715852 hasConcept C44249647 @default.
- W4381715852 hasConcept C71924100 @default.
- W4381715852 hasConceptScore W4381715852C121608353 @default.
- W4381715852 hasConceptScore W4381715852C126322002 @default.
- W4381715852 hasConceptScore W4381715852C126838900 @default.
- W4381715852 hasConceptScore W4381715852C142724271 @default.
- W4381715852 hasConceptScore W4381715852C2776235491 @default.
- W4381715852 hasConceptScore W4381715852C2777056448 @default.
- W4381715852 hasConceptScore W4381715852C2780192828 @default.
- W4381715852 hasConceptScore W4381715852C2781156865 @default.
- W4381715852 hasConceptScore W4381715852C2989005 @default.
- W4381715852 hasConceptScore W4381715852C44249647 @default.
- W4381715852 hasConceptScore W4381715852C71924100 @default.
- W4381715852 hasIssue "9" @default.
- W4381715852 hasLocation W43817158521 @default.
- W4381715852 hasLocation W43817158522 @default.
- W4381715852 hasOpenAccess W4381715852 @default.
- W4381715852 hasPrimaryLocation W43817158521 @default.
- W4381715852 hasRelatedWork W131936546 @default.
- W4381715852 hasRelatedWork W1497253641 @default.
- W4381715852 hasRelatedWork W2060381175 @default.
- W4381715852 hasRelatedWork W2075763133 @default.
- W4381715852 hasRelatedWork W2088520467 @default.
- W4381715852 hasRelatedWork W2348224142 @default.
- W4381715852 hasRelatedWork W2376423713 @default.
- W4381715852 hasRelatedWork W2386364393 @default.
- W4381715852 hasRelatedWork W3032731309 @default.
- W4381715852 hasRelatedWork W1583600832 @default.
- W4381715852 hasVolume "48" @default.
- W4381715852 isParatext "false" @default.
- W4381715852 isRetracted "false" @default.
- W4381715852 workType "article" @default.